Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bagshaw, 2010, Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference, Nephrol Dial Transplant, 25, 1406, 10.1093/ndt/gfq066
Ix, 2003, Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study, J Am Soc Nephrol, 14, 3233, 10.1097/01.ASN.0000095642.25603.7A
Sarnak, 2003, Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention, Circulation, 108, 2154, 10.1161/01.CIR.0000095676.90936.80
Shiba, 2011, Chronic kidney disease and heart failure – bidirectional close link and common therapeutic goal, J Cardiol, 57, 8, 10.1016/j.jjcc.2010.09.004
Matsuo, 2009, Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease, J Cardiol, 53, 232, 10.1016/j.jjcc.2008.11.010
Cruz, 2010, Heart–kidney interaction: epidemiology of cardiorenal syndromes, Int J Nephrol, 2011, 351291
Yamamoto, 2009, Classification of FABP isoforms and tissues based on quantitative evaluation of transcript levels of these isoforms in various rat tissues, Biotechnol Lett, 31, 1695, 10.1007/s10529-009-0065-7
Maatman, 1992, Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction, Biochem J, 288, 285, 10.1042/bj2880285
Kamijo, 2004, Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules, Am J Pathol, 165, 1243, 10.1016/S0002-9440(10)63384-6
Kamijo, 2004, Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease, J Lab Clin Med, 143, 23, 10.1016/j.lab.2003.08.001
McMahon, 2010, Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury, Kidney Int, 77, 657, 10.1038/ki.2010.5
Fukuda, 2009, Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease, Inter Med, 48, 1731, 10.2169/internalmedicine.48.2410
Hiki, 2009, Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease, J Cardiol, 53, 108, 10.1016/j.jjcc.2008.09.010
Matsuo, 2009, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan, Am J Kidney Dis, 53, 982, 10.1053/j.ajkd.2008.12.034
Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4
Masaki, 2011, Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation, J Cardiol, 57, 303, 10.1016/j.jjcc.2011.01.015
Miyazaki, 2010, Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting, Lipids Health Dis, 9, 122, 10.1186/1476-511X-9-122
Harjai, 2008, A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system, Am J Cardiol, 101, 812, 10.1016/j.amjcard.2007.10.051
Kamijo-Ikemori, 2011, Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients, Diabetes Care, 34, 691, 10.2337/dc10-1392
Veerkamp, 1991, Structural and functional features of different types of cytoplasmic fatty acid-binding proteins, Biochim Biophys Acta, 1081, 1, 10.1016/0005-2760(91)90244-C
Sasaki, 2009, Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy, Nephron Clin Pract, 112, 148, 10.1159/000214210
Oliver, 1994, Effects of glucose and fatty acids on myocardial ischemia and arrhythmias, Lancet, 343, 155, 10.1016/S0140-6736(94)90939-3
Matthys, 1984, Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage, Kidney Int, 26, 153, 10.1038/ki.1984.149
Cantor, 2008, B-type natriuretic peptide and serum unbound free fatty acid levels after contemporary percutaneous coronary intervention, J Invasive Cardiol, 20, 186
Guarda, 2005, Red wine reduces oxidative stress in patients with acute coronary syndrome, Int J Cardiol, 104, 35, 10.1016/j.ijcard.2004.10.013
Yamamoto, 2007, Renal L-type fatty acid-binding protein in acute ischemic injury, J Am Soc Nephrol, 18, 2894, 10.1681/ASN.2007010097
Noiri, 2009, Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury, Am J Physiol Renal Physiol, 296, 669, 10.1152/ajprenal.90513.2008
Nakamura, 2007, Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy, Am J Hypertens, 20, 1195
Nakamura, 2005, Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy, Diabetes Care, 28, 2728, 10.2337/diacare.28.11.2728